Skip to Content

Altabax Approval History

FDA Approved: Yes (First approved April 12, 2007)
Brand name: Altabax
Generic name: retapamulin
Dosage form: Ointment
Company: GlaxoSmithKline
Treatment for: Impetigo

Altabax (retapamulin) is a topical antibiotic indicated for the treatment of impetigo in adults and children aged 9 months and older.

Development History and FDA Approval Process for Altabax

DateArticle
Apr 13, 2007Approval GSK Announces FDA Approval of Altabax (Retapamulin Ointment), 1%
Dec 22, 2006GSK Receives Approvable Letter for Topical Antibiotic, Altabax (retapamulin ointment), 1%
Feb 14, 2006GlaxoSmithKline's Topical Antibacterial Retapamulin Accepted for Review by The U.S. Food and Drug Administration

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide